Alkermes plc (Nasdaq: ALKS) today announced the presentation of 10 posters at the upcoming 31st Annual Psych Congress (Psych Congress) in Orlando, Oct. 25-28, 2018. Poster presentations will include clinical and real-world...
Alkermes plc (Nasdaq: ALKS) today announced the presentation of 10 posters at the upcoming 31st Annual Psych Congress (Psych Congress) in Orlando, Oct. 25-28, 2018. Poster presentations will include clinical and real-world...
The global desalting and buffer exchange market is projected to grow at a CAGR of 10.0%. The global desalting and buffer exchange market is expected to reach USD 1,094.8 million by 2023 from USD 679.8 million in 2018, at a...
The global desalting and buffer exchange market is projected to grow at a CAGR of 10.0%. The global desalting and buffer exchange market is expected to reach USD 1,094.8 million by 2023 from USD 679.8 million in 2018, at a...
Cota Healthcare, a breakthrough health data and analytics company, today announced the publication of two papers in The Oncologist and JCO Clinical Cancer Informatics (JCO CCI), respectively. The papers provide further...
Cota Healthcare, a breakthrough health data and analytics company, today announced the publication of two papers in The Oncologist and JCO Clinical Cancer Informatics (JCO CCI), respectively. The papers provide further...
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed and commercialized the SpaceOAR® Hydrogel System to help reduce common and...
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Augmenix, Inc., a privately-held company that developed and commercialized the SpaceOAR® Hydrogel System to help reduce common and...
Timberline Knolls Residential Treatment Center and SunCloud Health are hosting a free, one night only screening of the compelling documentary, All of Me, 5:30 – 8:30 p.m., Tuesday, November 13, 2018 at the Damen Cinema,...
Timberline Knolls Residential Treatment Center and SunCloud Health are hosting a free, one night only screening of the compelling documentary, All of Me, 5:30 – 8:30 p.m., Tuesday, November 13, 2018 at the Damen Cinema,...
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today welcomed the approval of Verastem Oncology's...
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today welcomed the approval of Verastem Oncology's...
CarePredict, a leading AI-driven digital health company based in Fort Lauderdale, Florida and Menlo Park, California, has selected Lacuna Health, a wholly-owned subsidiary of Kindred Healthcare, LLC for an AI-powered...
CarePredict, a leading AI-driven digital health company based in Fort Lauderdale, Florida and Menlo Park, California, has selected Lacuna Health, a wholly-owned subsidiary of Kindred Healthcare, LLC for an AI-powered...
- Celebrity and her doctor join forces to stress the importance of communication between patients and healthcare providers -
- Celebrity and her doctor join forces to stress the importance of communication between patients and healthcare providers -
Medisafe, the leading digital medication management platform with nearly five million registered users worldwide, today announced the launch of a value-driven partnership model to better align interests with its life...
Medisafe, the leading digital medication management platform with nearly five million registered users worldwide, today announced the launch of a value-driven partnership model to better align interests with its life...
XERMELOTM is a first-in-class treatment option for patients whose refractory carcinoid syndrome diarrhea is inadequately controlled with somatostatin analogue (SSA) therapy alone2
XERMELOTM is a first-in-class treatment option for patients whose refractory carcinoid syndrome diarrhea is inadequately controlled with somatostatin analogue (SSA) therapy alone2
At the Gulf Coast Conference, Bruker announces the launch of the S2 POLAR™, a new multi-element benchtop analyzer based on polarized Energy Dispersive X-Ray Fluorescence (EDXRF). The S2 POLAR offers the same excellent...
At the Gulf Coast Conference, Bruker announces the launch of the S2 POLAR™, a new multi-element benchtop analyzer based on polarized Energy Dispersive X-Ray Fluorescence (EDXRF). The S2 POLAR offers the same excellent...
According to the new market research report "Nanocellulose Market by Type (Microfibrillated Cellulose, Cellulose Nanocrystals), Application (Pulp& paper, Composites & packaging, Biomedical & pharmaceuticals,...
According to the new market research report "Nanocellulose Market by Type (Microfibrillated Cellulose, Cellulose Nanocrystals), Application (Pulp& paper, Composites & packaging, Biomedical & pharmaceuticals,...
Variant Pharmaceuticals, Inc. (Variant), a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today Notice of Allowance for two U.S. patent applications covering...
Variant Pharmaceuticals, Inc. (Variant), a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today Notice of Allowance for two U.S. patent applications covering...
United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced the closing of their pending worldwide exclusive license and collaboration agreement for the development and...
United Therapeutics Corporation (Nasdaq: UTHR) and MannKind Corporation (Nasdaq: MNKD) today announced the closing of their pending worldwide exclusive license and collaboration agreement for the development and...
On September 28, 2018, the President signed the Department of Defense and Labor (DOD), Health and Human Services, and Education (LHHS) Appropriations Act of 2019, an appropriations bill that provides FY2019 funding for...
On September 28, 2018, the President signed the Department of Defense and Labor (DOD), Health and Human Services, and Education (LHHS) Appropriations Act of 2019, an appropriations bill that provides FY2019 funding for...
BioInvent International AB (OMXS: BINV) today announced its intention to initiate three new clinical programs in solid cancer. In addition to the previously disclosed programs (BI-1206 + rituximab – projected topline...
BioInvent International AB (OMXS: BINV) today announced its intention to initiate three new clinical programs in solid cancer. In addition to the previously disclosed programs (BI-1206 + rituximab – projected topline...
Amgen (NASDAQ:AMGN) today announced that AMGEVITATM, a biosimilar to adalimumab, will launch in markets across Europe beginning on Oct. 16, 2018. AMGEVITA is the first adalimumab biosimilar to be approved by the European...
Amgen (NASDAQ:AMGN) today announced that AMGEVITATM, a biosimilar to adalimumab, will launch in markets across Europe beginning on Oct. 16, 2018. AMGEVITA is the first adalimumab biosimilar to be approved by the European...
MISSISSAUGA, ON, Oct. 15, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in European specialty,...
MISSISSAUGA, ON, Oct. 15, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in European specialty,...
The Columbia-Inland Medical Pumper Car has been designated by the U.S. Food and Drug Administration (FDA) as non-measuring exercise device intended for medical purposes. Pumper Cars originally were designed as a fun...
The Columbia-Inland Medical Pumper Car has been designated by the U.S. Food and Drug Administration (FDA) as non-measuring exercise device intended for medical purposes. Pumper Cars originally were designed as a fun...
Arcadier, a Singapore-headquartered online marketplace builder, has been chosen by the United Nations Office for Project Services' (UNOPS) Defeat-NCD (Non-Communicable Disease) Partnership as the partner for their...
Arcadier, a Singapore-headquartered online marketplace builder, has been chosen by the United Nations Office for Project Services' (UNOPS) Defeat-NCD (Non-Communicable Disease) Partnership as the partner for their...
Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the completion of a $95 million financing led by Nikon and backed by existing investors Sequoia Capital, Walden-Riverwood Ventures, Black...
Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the completion of a $95 million financing led by Nikon and backed by existing investors Sequoia Capital, Walden-Riverwood Ventures, Black...
The global duchenne muscular dystrophy (DMD) drugs market size is expected to reach USD 4.11 billion by 2023, according to a new report by Grand View Research, Inc., expanding at a CAGR of 41.3% during the forecast period....
The global duchenne muscular dystrophy (DMD) drugs market size is expected to reach USD 4.11 billion by 2023, according to a new report by Grand View Research, Inc., expanding at a CAGR of 41.3% during the forecast period....
OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has initiated KEYNOTE-890, a Phase 2 clinical trial for the treatment of late-stage...
OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has initiated KEYNOTE-890, a Phase 2 clinical trial for the treatment of late-stage...
Diagnomics Inc., a San Diego-based genomics solution provider, has extended its product portfolio to include pharmacogenetic (PGx) reporting through a strategic partnership with Translational Software Inc. (TSI)....
Diagnomics Inc., a San Diego-based genomics solution provider, has extended its product portfolio to include pharmacogenetic (PGx) reporting through a strategic partnership with Translational Software Inc. (TSI)....
As per expert analysts, the global patient registry software market is estimated to register an overall valuation of US$2.0 bn by 2023, which is a decent growth from an initial revenue worth US$1.0 bn that was clocked in...
As per expert analysts, the global patient registry software market is estimated to register an overall valuation of US$2.0 bn by 2023, which is a decent growth from an initial revenue worth US$1.0 bn that was clocked in...
Eli Lilly and Company (NYSE: LLY) announced that it will present new data for Taltz® (ixekizumab) and Olumiant® (baricitinib) at the American College of Rheumatology (ACR)/Association of Rheumatology Health Professionals...
Eli Lilly and Company (NYSE: LLY) announced that it will present new data for Taltz® (ixekizumab) and Olumiant® (baricitinib) at the American College of Rheumatology (ACR)/Association of Rheumatology Health Professionals...
Modality Solutions, a privately-held company that delivers integrated cold chain operations solutions for highly regulated industries, is a silver sponsor and exhibitor at the Executive Platforms' Biomanufacturing...
Modality Solutions, a privately-held company that delivers integrated cold chain operations solutions for highly regulated industries, is a silver sponsor and exhibitor at the Executive Platforms' Biomanufacturing...
Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the...
Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...
Medivir AB (Nasdaq Stockholm: MVIR) announced today its plans to concentrate its activities on clinical development. As a result, the board has appointed Dr. Uli Hacksell as the company's acting CEO. Dr. Hacksell,...
Medivir AB (Nasdaq Stockholm: MVIR) announced today its plans to concentrate its activities on clinical development. As a result, the board has appointed Dr. Uli Hacksell as the company's acting CEO. Dr. Hacksell,...
Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make...
Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make...
Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation to introduce various cardiovascular catheters into the left heart...
Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation to introduce various cardiovascular catheters into the left heart...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that positive new data from multiple studies of YUPELRI™ (revefenacin) inhalation solution were...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced that positive new data from multiple studies of YUPELRI™ (revefenacin) inhalation solution were...
Unique discovery platform generates new antibody candidates that block a root cause of Parkinson's Disease
Unique discovery platform generates new antibody candidates that block a root cause of Parkinson's Disease
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for fostamatinib in adult chronic immune thrombocytopenia. The...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for fostamatinib in adult chronic immune thrombocytopenia. The...
Bristol-Myers Squibb Company (NYSE: BMY) and Compugen (NASDAQ: CGEN) today announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugen's COM701, an...
Bristol-Myers Squibb Company (NYSE: BMY) and Compugen (NASDAQ: CGEN) today announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugen's COM701, an...
One-year results from the Phase 2 study evaluating STELARA® (ustekinumab) in patients with active systemic lupus erythematosus featured in a plenary presentation 13 presentations from approved and pipeline products...
One-year results from the Phase 2 study evaluating STELARA® (ustekinumab) in patients with active systemic lupus erythematosus featured in a plenary presentation 13 presentations from approved and pipeline products...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will be presenting results from 20 abstracts across the company's rheumatology portfolio and pipeline products during the 2018...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will be presenting results from 20 abstracts across the company's rheumatology portfolio and pipeline products during the 2018...
Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that its Group Business, Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical...
Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that its Group Business, Pharmaxis Ltd (ASX: PXS), an Australian pharmaceutical...
Exclusive worldwide licence deal adding to Carrick's rapid pipeline expansionPreparations for pivotal studies underwayDr. George Golumbeski appointed as Chairman of the Board Carrick Therapeutics, a biopharmaceutical...
Exclusive worldwide licence deal adding to Carrick's rapid pipeline expansionPreparations for pivotal studies underwayDr. George Golumbeski appointed as Chairman of the Board Carrick Therapeutics, a biopharmaceutical...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Oct 10, 2018 /PRNewswire/ -- The "Blister Packaging Market in the US 2018-2022" report has been added to ResearchAndMarkets.com's offering. The blister pac...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, Oct 10, 2018 /PRNewswire/ -- The "Blister Packaging Market in the US 2018-2022" report has been added to ResearchAndMarkets.com's offering. The blister pac...
The Department of Culture and Tourism - Abu Dhabi (DCT Abu Dhabi) has signed a Memorandum of Understanding with the Medical Tourism Association® (MTA), to coordinate efforts to position Abu Dhabi as a world-class medical...
The Department of Culture and Tourism - Abu Dhabi (DCT Abu Dhabi) has signed a Memorandum of Understanding with the Medical Tourism Association® (MTA), to coordinate efforts to position Abu Dhabi as a world-class medical...
S&R Foundation, a non-profit organization that supports talented individuals with high aspirations in the arts, sciences, and social entrepreneurship, is pleased to announce that the 2018?Sachiko Kuno Award for Applied...
S&R Foundation, a non-profit organization that supports talented individuals with high aspirations in the arts, sciences, and social entrepreneurship, is pleased to announce that the 2018?Sachiko Kuno Award for Applied...
According to the Corporate Whistleblower Center, "Without going into details, we may soon be the most quoted source in the nation when it comes to illegal activity in long term care, nursing homes, and/or acute treatment...
According to the Corporate Whistleblower Center, "Without going into details, we may soon be the most quoted source in the nation when it comes to illegal activity in long term care, nursing homes, and/or acute treatment...
SpineEX, Inc., a medical device company that aims to provide innovative and minimally invasive implants, high-value disposables and instrumentation for spinal fusion surgeries, announced today it has received 510(k)...
SpineEX, Inc., a medical device company that aims to provide innovative and minimally invasive implants, high-value disposables and instrumentation for spinal fusion surgeries, announced today it has received 510(k)...
NASDAQ, TSX: NVCN
NASDAQ, TSX: NVCN
Global Glycolic Acid Market is anticipated to reach USD 415.0 million by 2024. Glycolic acid falls in the category of alpha hydroxy acid (AHA). Glycolic acid is colorless, odorless, hygroscopic crystalline solid....
Global Glycolic Acid Market is anticipated to reach USD 415.0 million by 2024. Glycolic acid falls in the category of alpha hydroxy acid (AHA). Glycolic acid is colorless, odorless, hygroscopic crystalline solid....
Real-world evidence and longer clinical trial follow-up show no increased incidence of serious adverse events Additional post-hoc data analyses support sustained efficacy of cladribine tablets in patients with ...
Real-world evidence and longer clinical trial follow-up show no increased incidence of serious adverse events Additional post-hoc data analyses support sustained efficacy of cladribine tablets in patients with ...
Eisai Inc. announced today the presentation of six abstracts featuring data and analyses on its cancer treatments at the European Society of Medical Oncology (ESMO) 2018 Congress taking place in Munich from October 19-23....
Eisai Inc. announced today the presentation of six abstracts featuring data and analyses on its cancer treatments at the European Society of Medical Oncology (ESMO) 2018 Congress taking place in Munich from October 19-23....
This report discusses the market for bone cement used in large joint procedures. In 2017, the bone cement market, including traditional (non-antibiotic-containing) bone cement and premixed antibiotic bone cement, was...
This report discusses the market for bone cement used in large joint procedures. In 2017, the bone cement market, including traditional (non-antibiotic-containing) bone cement and premixed antibiotic bone cement, was...
In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing...
In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing...
Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual...
Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual...
Astellas today issued its third-annual Americas Corporate Social Responsibility (CSR) Report Card. The Report Card, which can be found here, outlines the company's progress made during Fiscal Year 2017 to fulfill its...
Astellas today issued its third-annual Americas Corporate Social Responsibility (CSR) Report Card. The Report Card, which can be found here, outlines the company's progress made during Fiscal Year 2017 to fulfill its...
On October 10, in celebration of New York's 4th annual Organ Donor Enrollment Day, launched and led by LiveOnNY, thousands around New York will be given a gift, an extra 15-minute break during their work day. Employers...
On October 10, in celebration of New York's 4th annual Organ Donor Enrollment Day, launched and led by LiveOnNY, thousands around New York will be given a gift, an extra 15-minute break during their work day. Employers...
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a key first step in the...
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a key first step in the...
Cellecta, Inc. today introduced the CloneTracker XP™ Expressed Lentiviral Barcode Library and CloneTracker XP™ Barcoded CRISPR Library product lines. The ability to label and trace individual cells is a powerful...
Cellecta, Inc. today introduced the CloneTracker XP™ Expressed Lentiviral Barcode Library and CloneTracker XP™ Barcoded CRISPR Library product lines. The ability to label and trace individual cells is a powerful...
The world downstream bioprocessing market reached $11 billion in 2017, according to Kalorama Information. Downstream bioprocessing involves the recovery and purification of biosynthetic products, often pharmaceuticals,...
The world downstream bioprocessing market reached $11 billion in 2017, according to Kalorama Information. Downstream bioprocessing involves the recovery and purification of biosynthetic products, often pharmaceuticals,...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data showing treatment with a single intravenous (IV) dose of STELARA® (ustekinumab) induces clinical remission and response in adults with...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data showing treatment with a single intravenous (IV) dose of STELARA® (ustekinumab) induces clinical remission and response in adults with...
The Johnson & Johnson Medical Devices Companies* today announced the results of an Ethicon** clinical study showing that its LINX Reflux Management System, a small band of magnetic beads that surgeons wrap around the...
The Johnson & Johnson Medical Devices Companies* today announced the results of an Ethicon** clinical study showing that its LINX Reflux Management System, a small band of magnetic beads that surgeons wrap around the...
Results of a three-part survey of those living with narcolepsy (n=200), treating physicians (n=251) and the general public (n=1,203) bring to light the serious impact of this rare, chronic neurologic disorder on daily...
Results of a three-part survey of those living with narcolepsy (n=200), treating physicians (n=251) and the general public (n=1,203) bring to light the serious impact of this rare, chronic neurologic disorder on daily...
Variant Pharmaceuticals, Inc, a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today appointments of three new Board members, Robert (Rob) G. Finizio, Anthony...
Variant Pharmaceuticals, Inc, a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today appointments of three new Board members, Robert (Rob) G. Finizio, Anthony...
- ADVANZ PHARMA represents the Company's vision to go beyond expectations to bring sustainable value to customers, healthcare providers, and patients -
- ADVANZ PHARMA represents the Company's vision to go beyond expectations to bring sustainable value to customers, healthcare providers, and patients -
Driven by the availability of Merck KGaA's Mavenclad and substantial uptake of Biogen's Tecfidera, the oral disease-modifying therapy (DMT) class share of DMT-treated multiple sclerosis (MS) patients increased...
Driven by the availability of Merck KGaA's Mavenclad and substantial uptake of Biogen's Tecfidera, the oral disease-modifying therapy (DMT) class share of DMT-treated multiple sclerosis (MS) patients increased...
Bayer will present new data from the company's growing oncology portfolio at the ESMO 2018 Congress (European Society for Medical Oncology) taking place October 19-23 in Munich, Germany.
Bayer will present new data from the company's growing oncology portfolio at the ESMO 2018 Congress (European Society for Medical Oncology) taking place October 19-23 in Munich, Germany.
Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its healthcare business in the U.S. and Canada as EMD Serono, today announced that new data from a variety of high-priority clinical...
Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its healthcare business in the U.S. and Canada as EMD Serono, today announced that new data from a variety of high-priority clinical...
Eli Lilly and Company (NYSE: LLY) will present new data from its clinical development program at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany, October 19-23. Data presented showcase how...
Eli Lilly and Company (NYSE: LLY) will present new data from its clinical development program at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany, October 19-23. Data presented showcase how...
The report analyses the Super Absorbent Polymer Market Analysis By Type (Sodium Polyacrylate, Polyacrylamide Copolymer, Others) and by End-Use Sector (Personal Care, Agriculture, Medical, Industrial, Others). The report...
The report analyses the Super Absorbent Polymer Market Analysis By Type (Sodium Polyacrylate, Polyacrylamide Copolymer, Others) and by End-Use Sector (Personal Care, Agriculture, Medical, Industrial, Others). The report...
OccuPro, a company providing medical professionals and employers with the latest in functional capacity evaluation software and continuing education, is highlighting a 2018 publication titled "An evaluation of the...
OccuPro, a company providing medical professionals and employers with the latest in functional capacity evaluation software and continuing education, is highlighting a 2018 publication titled "An evaluation of the...
Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health...
Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health...
Takeda Pharmaceuticals U.S.A., Inc., ("Takeda") today announced the presentation of new long-term efficacy real-world data analyses for Entyvio® (vedolizumab) at ACG 2018 in Philadelphia, PA. Studies of note include a...
Takeda Pharmaceuticals U.S.A., Inc., ("Takeda") today announced the presentation of new long-term efficacy real-world data analyses for Entyvio® (vedolizumab) at ACG 2018 in Philadelphia, PA. Studies of note include a...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at IDWeek™ 2018, which was held in...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at IDWeek™ 2018, which was held in...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the presentation of...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the presentation of...
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the U.S. Food and Drug Administration...
Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the U.S. Food and Drug Administration...
Late-breaking Phase II primary endpoint data for investigational therapy evobrutinib, the first oral BTK inhibitor to show clinical proof-of-concept in RMS Up to 10 years of patient experience provides further insight into...
Late-breaking Phase II primary endpoint data for investigational therapy evobrutinib, the first oral BTK inhibitor to show clinical proof-of-concept in RMS Up to 10 years of patient experience provides further insight into...
DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading independent provider of integrated health and kidney care services in the United States, today announced DaVita Hospital Services has received its second...
DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading independent provider of integrated health and kidney care services in the United States, today announced DaVita Hospital Services has received its second...
Vivos Therapeutics, a leading company focused on addressing the root causes of mild-to-moderate sleep apnea, convened the inaugural "Breathing Wellness Conference". Dental industry leaders shared discoveries, patient...
Vivos Therapeutics, a leading company focused on addressing the root causes of mild-to-moderate sleep apnea, convened the inaugural "Breathing Wellness Conference". Dental industry leaders shared discoveries, patient...
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the presentation of updated data from the...
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the presentation of updated data from the...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced preliminary data from the first international drug registry for Duchenne patients receiving Translarna™ (ataluren), underscoring the long-term clinical benefit of...
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced preliminary data from the first international drug registry for Duchenne patients receiving Translarna™ (ataluren), underscoring the long-term clinical benefit of...
Vero Biotech LLC, a biopharmaceutical company focused on the design, development and commercialization of next generation inhaled nitric oxide (NO), today announced the appointment of Michael Gentile, MBA, RRT, FAARC,...
Vero Biotech LLC, a biopharmaceutical company focused on the design, development and commercialization of next generation inhaled nitric oxide (NO), today announced the appointment of Michael Gentile, MBA, RRT, FAARC,...
MISSISSAUGA, ON, Oct. 5, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in European specialty,...
MISSISSAUGA, ON, Oct. 5, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR), an international specialty pharmaceutical company focused on becoming a leader in European specialty,...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Audentes Therapeutics, Inc. - Significant continued improvements in neuromuscular and respiratory function observed in all treated patients, with follow-up assessments ranging from 4...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Audentes Therapeutics, Inc. - Significant continued improvements in neuromuscular and respiratory function observed in all treated patients, with follow-up assessments ranging from 4...
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer, today announced topline results...
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer, today announced topline results...
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have jointly produced and presented today at the EASD's Annual Meeting in Berlin a new guidance document Management...
The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have jointly produced and presented today at the EASD's Annual Meeting in Berlin a new guidance document Management...
Aniara Diagnostica, a multinational distributor, has strengthened its commitment to meeting todays highest Industrial QC Heparin standards by launching http://www.heparinassay.com
Aniara Diagnostica, a multinational distributor, has strengthened its commitment to meeting todays highest Industrial QC Heparin standards by launching http://www.heparinassay.com
The InforMing the PAthway of COPD Treatment (IMPACT) study was conducted to assess the benefits of triple versus dual therapy in patients with COPD. In a study at CHEST, researchers found that regardless of baseline...
The InforMing the PAthway of COPD Treatment (IMPACT) study was conducted to assess the benefits of triple versus dual therapy in patients with COPD. In a study at CHEST, researchers found that regardless of baseline...
What our ability to provide this exciting new technology means for our LASIK patients:
What our ability to provide this exciting new technology means for our LASIK patients:
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the publication of nonclinical data for PEGPH20 in Clinical Cancer Research, an...
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the publication of nonclinical data for PEGPH20 in Clinical Cancer Research, an...
Cohen Veterans Bioscience, a Cambridge, MA based 501c3 non-profit research organization will establish a clinical trial infrastructure and serve as the Clinical Coordinating Center for a 3.5-year study to comparatively...
Cohen Veterans Bioscience, a Cambridge, MA based 501c3 non-profit research organization will establish a clinical trial infrastructure and serve as the Clinical Coordinating Center for a 3.5-year study to comparatively...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Janssen Pharmaceuticals, Inc., (Janssen) has entered into an agreement with Arrowhead Pharmaceuticals, Inc., (Arrowhead) for an exclusive,...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that Janssen Pharmaceuticals, Inc., (Janssen) has entered into an agreement with Arrowhead Pharmaceuticals, Inc., (Arrowhead) for an exclusive,...
MilliporeSigma today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region. The center will provide Life Science customers with a shared, exploratory environment where...
MilliporeSigma today officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil, serving the Latin America region. The center will provide Life Science customers with a shared, exploratory environment where...
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced it...
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced it...
Eisai Inc. announced today new data on prevention and remission of diabetes from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients treated with anti-obesity agent BELVIQ® (lorcaserin HCl) CIV 10 mg...
Eisai Inc. announced today new data on prevention and remission of diabetes from the CAMELLIA-TIMI 61 cardiovascular (CV) outcomes trial in patients treated with anti-obesity agent BELVIQ® (lorcaserin HCl) CIV 10 mg...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the results from the...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the results from the...
VANCOUVER, Oct. 4, 2018 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs...
VANCOUVER, Oct. 4, 2018 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs...
Upsurge in geriatric population and rise in the number of patients with chronic health conditions are expected to boost the growth of the global enteral nutrition market. According to a new report published by Allied...
Upsurge in geriatric population and rise in the number of patients with chronic health conditions are expected to boost the growth of the global enteral nutrition market. According to a new report published by Allied...
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today that empagliflozin met the primary efficacy endpoint, defined as a change from baseline in A1C versus placebo after 26 weeks of treatment, for all...
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced today that empagliflozin met the primary efficacy endpoint, defined as a change from baseline in A1C versus placebo after 26 weeks of treatment, for all...
Seqirus, a global leader in influenza prevention, will present new healthcare and cost outcomes data for its MF59®-adjuvanted trivalent influenza vaccine (FLUAD) at IDWeek in San Francisco (October 5-6). Results from five...
Seqirus, a global leader in influenza prevention, will present new healthcare and cost outcomes data for its MF59®-adjuvanted trivalent influenza vaccine (FLUAD) at IDWeek in San Francisco (October 5-6). Results from five...
The Janssen Pharmaceutical Companies of Johnson & Johnson unveils new 96-week data for SYMTUZA™ (darunavir 200 mg, cobicistat 150 mg, emtricitabine 200mg, and tenofovir alafenamide 10 mg; D/C/F/TAF), a single-tablet...
The Janssen Pharmaceutical Companies of Johnson & Johnson unveils new 96-week data for SYMTUZA™ (darunavir 200 mg, cobicistat 150 mg, emtricitabine 200mg, and tenofovir alafenamide 10 mg; D/C/F/TAF), a single-tablet...
DaVita Inc.(NYSE: DVA), a health care services provider of kidney care, clinical research and care to the chronically ill, today acknowledged its collective achievements in improving clinical outcomes and research so far...
DaVita Inc.(NYSE: DVA), a health care services provider of kidney care, clinical research and care to the chronically ill, today acknowledged its collective achievements in improving clinical outcomes and research so far...
Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and reduced drug spending for diabetes -- one of America's deadliest and most costly health conditions.
Express Scripts (NASDAQ: ESRX) released new data today showing significantly improved clinical outcomes and reduced drug spending for diabetes -- one of America's deadliest and most costly health conditions.
